New Federal Contractors — June 12, 2026

Partner Therapeutics, a small business, secured a $133.5M firm-fixed-price delivery order from HHS/ASPR for Leukine, with $83.5M already outlaid (62.5% funded). This provides strong near-term revenue visibility through March 2027 and signals sustained government investment in medical preparedness.

MANTECH Advanced Systems International won a $452M cost-plus-fixed-fee R&D contract from GSA FEDSIM through June 2027. The full-and-open competition win against other large primes signals strong competitive standing, and the cost-plus structure reduces profit risk.

Caddell Construction won a $322.4M firm-fixed-price contract from the Department of State for the Rio New Consulate Compound. Fixed-price pricing on a complex overseas construction project transfers cost overrun risk to the contractor, with performance through February 2027.

ACUMEN LLC's $167.3M time-and-materials delivery order from CMS for administrative management consulting has $149.7M already outlayed, indicating high contract utilization and stable cash flows through September 2026.

SAIC's $290.8M cost-plus award fee contract from GSA for EPA end user support ended in September 2022. The negative outlay of -$1.4M suggests potential underperformance or funding adjustments, though no current revenue impact.

Caddell Construction's $322.4M firm-fixed-price contract for the Rio New Consulate Compound carries significant execution risk on a complex overseas construction project. Cost overruns would directly impact margins.

MAXIMUS Federal Services' $92.3M IRS IT contract has only $30.6M outlayed (33.2% of total obligation), suggesting phased funding that could be vulnerable to budget constraints or IRS funding cuts.

The digest shows heavy civilian agency concentration with 9 of 10 contracts from civilian agencies ($1.4B total). Only 1 defense contract ($452M) is included, limiting exposure to defense budget growth.

JAG KETCHIKAN, LLC, a small business, won a $99.6M firm-fixed-price NOAA ship modernization contract under full-and-open competition. The company's financial capacity to manage a contract of this size is unproven.

MANTECH's $452M GSA R&D contract through 2027 provides a stable revenue base. Follow-on awards from GSA FEDSIM or other agencies could expand this footprint, especially in applied research and exploratory development.

Partner Therapeutics' $133.5M Leukine contract from HHS/ASPR signals sustained government investment in medical preparedness. Future procurement plans for similar products could provide additional revenue streams.

Only 1 of 10 contracts is defense-related, suggesting potential for increased defense contract awards. Investors should monitor DOD budget trends and NDAA priorities for future opportunities.

Multiple contracts (SAIC $290.8M, Peraton $121.6M, MAXIMUS $92.3M, CTIS $85.6M) support IT application development, help desk, and modernization services for civilian agencies like EPA, GSA, IRS, and NIH. This indicates sustained demand for IT support across government.

Three HHS contracts (Partner Therapeutics $133.5M, CTIS $85.6M, ABT Global $83.8M) total $302.9M, supporting pharmaceutical preparedness, cancer research IT, and mental health research. This reflects bipartisan support for health security and research funding.

Caddell Construction ($322.4M) and JAG KETCHIKAN ($99.6M) won large construction and ship modernization contracts from State Department and NOAA, respectively. This indicates continued investment in diplomatic facilities and marine research infrastructure.

{"entity"=>"MANTECH INTERNATIONAL CORPORATION", "reason"=>"Largest contract in the digest ($452M) with multi-year R&D revenue visibility through 2027. Follow-on awards from GSA FEDSIM could signal market share trends.", "trigger"=>"Quarterly filings for revenue contribution from this task order; subsequent GSA FEDSIM R&D awards"}

{"entity"=>"Partner Therapeutics, Inc.", "reason"=>"Bullish $133.5M Leukine contract with $83.5M already funded. Future ASPR procurement plans could expand this revenue stream.", "trigger"=>"Financial reports for revenue recognition; ASPR future procurement announcements for Leukine or similar products"}

{"entity"=>"CADDELL CONSTRUCTION CO. (DE), LLC", "reason"=>"High-risk $322.4M firm-fixed-price consulate contract. Cost overruns or delays could materially impact margins.", "trigger"=>"Quarterly earnings for revenue recognition; contract modifications or cost overrun disclosures"}

{"entity"=>"MAXIMUS FEDERAL SERVICES, INC.", "reason"=>"IRS IT contract with only 33.2% outlayed. Budget constraints could affect full contract utilization.", "trigger"=>"Outlay rate vs. total obligation; IRS IT budget trends; option exercise announcements"}